Stabilized p53 peptides and uses thereof
Details for Australian Patent Application No. 2008210434 (hide)
International Classifications
Event Publications
20 August 2009 PCT application entered the National Phase
PCT publication WO2008/095063 Priority application(s): WO2008/095063
3 September 2009 Amendment Made
The nature of the amendment is: Amend the applicant name name to President & Fellows of Harvard College
8 October 2009 Amendment Made
The nature of the amendment is: Amend applicant name From: DANA-FARBER CANCER INSTITUTE, INC.; President & Fellows of Harvard College to: DANA-FARBER CANCER INSTITUTE, INC.; President and Fellows of Harvard College
17 December 2009 Corrigenda
PCT applications that have entered the National Phase - Name Index Under the Name DANA-FARBER CANCER INSTITUTE, INC.; President and Fellows of Harvard College, Application No. 2008210434, under INID (72) correct the inventors to include co-inventor Korsmeyer, Stanley
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008210455-2-aminopyridine derivatives useful as kinase inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser
